TrialInternational journal of hematology2020

Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia.

Hidefumi Hiramatsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.